These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 31484323)
41. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011 [TBL] [Abstract][Full Text] [Related]
42. Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice. Hu Y; Yin F; Liu Z; Xie H; Xu Y; Zhou D; Zhu B Food Funct; 2020 Jan; 11(1):1037-1048. PubMed ID: 31819934 [TBL] [Abstract][Full Text] [Related]
43. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437 [TBL] [Abstract][Full Text] [Related]
44. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation. Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075 [TBL] [Abstract][Full Text] [Related]
45. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529 [TBL] [Abstract][Full Text] [Related]
46. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220 [TBL] [Abstract][Full Text] [Related]
47. Pea Albumin Extracted from Pea ( Zhang S; Cui Z; Zhang H; Wang P; Wang F; Zhang J Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064674 [TBL] [Abstract][Full Text] [Related]
48. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways. Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068 [TBL] [Abstract][Full Text] [Related]
50. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. Fu D; Cui H; Zhang Y Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812 [TBL] [Abstract][Full Text] [Related]
51. Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells. Hwang YJ; Wi HR; Kim HR; Park KW; Hwang KA Nutrients; 2014 Jul; 6(7):2956-72. PubMed ID: 25057104 [TBL] [Abstract][Full Text] [Related]
52. Quinoa Polyphenol Extract Alleviates Non-Alcoholic Fatty Liver Disease via Inhibiting Lipid Accumulation, Inflammation and Oxidative Stress. Yao W; Fan M; Qian H; Li Y; Wang L Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064719 [TBL] [Abstract][Full Text] [Related]
53. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice. Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698 [TBL] [Abstract][Full Text] [Related]
54. Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress. Alharbi S Biomed Pharmacother; 2022 Jul; 151():113095. PubMed ID: 35594708 [TBL] [Abstract][Full Text] [Related]
55. Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet. Pérez-Martínez L; Ochoa-Callejero L; Rubio-Mediavilla S; Narro J; Bernardo I; Oteo JA; Blanco JR Transl Res; 2018 Jun; 196():17-30. PubMed ID: 29421523 [TBL] [Abstract][Full Text] [Related]
56. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice. Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386 [TBL] [Abstract][Full Text] [Related]
58. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study. Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947 [TBL] [Abstract][Full Text] [Related]
59. Anti-obesity effects of boiled tuna extract in mice with obesity induced by a high-fat diet. Kim Y; Kwon MJ; Choi JW; Lee MK; Kim C; Jung J; Aprianita H; Nam H; Nam TJ Int J Mol Med; 2016 Oct; 38(4):1281-8. PubMed ID: 27498820 [TBL] [Abstract][Full Text] [Related]
60. Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3. Ma L; Li H; Hu J; Zheng J; Zhou J; Botchlett R; Matthews D; Zeng T; Chen L; Xiao X; Athrey G; Threadgill DW; Li Q; Glaser S; Francis H; Meng F; Li Q; Alpini G; Wu C Hepatology; 2020 Oct; 72(4):1191-1203. PubMed ID: 31953865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]